First Tracks Biotherapeutics, Inc. · NASDAQ:TRAX

BlackRock, Inc. reported a 5.50% stake in First Tracks Biotherapeutics, Inc. (Schedule 13G)

Event Jun 30, 2026 · Filed Jul 28, 2026

BlackRock, Inc. reported a 5.50% stake in First Tracks Biotherapeutics, Inc., 1,919,376 shares, as a passive investor on Jun 30, 2026. Filed Jul 28, 2026 (Schedule 13G).

Stake
5.50%
Shares
1,919,376
Intent
Passive
What changed
Crossed above 5%

The filing in full

HolderStakeShares
BlackRock, Inc.5.50%1,919,376

Source

View original at SEC

Related